. Immunohistochemical analysis of primate brain GVHD. Rhesus macaques used in this study were housed at the Yerkes National Primate Research Center and treated in accordance with Emory University Institutional Animal Care and Use Committee regulations. The following experimental groups were assessed: (1) healthy untransplanted controls (n 5 4); (2) autologous transplanted controls (n 5 3); (3) recipients of MHC-mismatched allogeneic HCT that did not receive GVHD prophylaxis (n 5 5, mean survival time (MST) 5 7 days); (4) allogeneic HCT recipients treated with rapamycin monotherapy (n 5 6, MST 5 17 days); and (5) For personal use only. on November 13, 2017. by guest www.bloodjournal.org From model and that CNS GVHD is predominantly mediated by integrinexpressing CD8 1 T cells.
Using immunohistochemistry (IHC), we studied the meninges, cerebral vasculature, and parenchyma from NHPs that had been transplanted according to our previously described protocol for myeloablative MHC-mismatched hematopoietic cell transplant (HCT). 5 We had previously shown that animals transplanted without posttransplant immunosuppression displayed classic stigmata of gut and liver GVHD, as well as significant lassitude, and the acute onset of behavioral depression. 5 Infiltrates were found in all 3 CNS areas ( Figure 1A-C) , with the most striking results occurring in the meninges. As shown in Figure 1A- The phenotype of the infiltrating CD8 1 lymphocytes demonstrated evidence of cytotoxicity (granzyme B) and proliferation (Ki-67; Figure 1A -B,D). Additionally, lymphocyte functionassociated antigen-1 (LFA-1) integrin expression was highly upregulated ( Figure 1A-B) . Given the central role that LFA-1 plays in CNS leukocyte trafficking during demyelinating disease, 8 these results suggest that the mechanisms of CNS T-cell infiltration during GVHD may have important similarities to those in autoimmunity and may be amenable to similar integrin-targeting therapies. 9 In addition to CD8
1 T cells, CD163 1 cells (macrophage/monocytes) 10 were also observed in GVHD, suggesting that infiltration of antigen presenting cells may also characterize CNS disease.
As shown in Figure 1A -B, we observed that 2 GVHD prophylaxis regimens (either tacrolimus/methotrexate or rapamycin monotherapy) both significantly decreased the GVHD-associated CD8 1 infiltration. However, neither completely abrogated T-cell proliferation compared with untransplanted animals, suggesting breakthrough alloproliferation (potentially in situ, via allorecognition of host microglia, astrocytes, and other cells) with both of these regimens. These studies also document the ability to measure this breakthrough proliferation in the primate model.
Our results suggest that, in primates as in mice, 1 the behavioral abnormalities that accompany severe GVHD may have an anatomical correlation with T-cell infiltration into the brain, and that CNS disease may significantly contribute to GVHD morbidity. 5 This infiltration is skewed toward proliferating, CD8 Although the current experiments were limited by the difficulty in performing confirmatory functional radiologic examination in NHP, this report represents the first study linking behavioral and histopathological evidence for brain GVHD in primates and suggests that this increasingly appreciated manifestation of GVHD is deserving of further clinical scrutiny.
